NYSE:SYK
Stryker Corp. (SYK)
Financials 
Technical Analysis 
Sep 5, 2026, 12:00 amThis summary was created by AI, based on 8 opinions in the last 12 months.
Stryker Corp. (SYK) is a leading player in the medical device sector, particularly in orthopedics, with a notable 70% market share in the U.S. robotics platform. The company, which primarily generates its revenue from the U.S. market, is seen as well-positioned to capitalize on the aging population, as demand for hip, knee, shoulder, and spine procedures increases. Despite recent challenges, including a cybersecurity attack and overall weakness in the health sector, analysts are optimistic about SYK's recovery potential and growth trajectory. Furthermore, Stryker's solid relationships with medical professionals and a consistent dividend increase bolster the investment case. Most analysts express confidence in SYK's ability to achieve substantial earnings per share growth while maintaining an attractive valuation in a growing market.
Medical devices. Has grown through acquisition. Long track record of dividend growth and have grown 25% over the last 5 years. Trading at around 16X earnings.
John O'Connell, CFA
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Sees opportunities in developing markets and demographics play a good role. Feels their abilities and for similar companies in the medical device area, is to participate with the goal of lowering costs. Companies like this that make the devices, have the opportunity to help lower costs, which will be better for consumers and governments and will ultimately provide better care. Long-term theme.